Mustang Bio Stock Z Score
| MBIO Stock | USD 0.34 0.03 8.11% |
Mustang | Z Score |
Mustang Bio Company Z Score Analysis
Mustang Bio's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
Mustang Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Mustang Bio is extremely important. It helps to project a fair market value of Mustang Stock properly, considering its historical fundamentals such as Z Score. Since Mustang Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Mustang Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Mustang Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
| Competition |
Based on the company's disclosures, Mustang Bio has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.
Mustang Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mustang Bio's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mustang Bio could also be used in its relative valuation, which is a method of valuing Mustang Bio by comparing valuation metrics of similar companies.Mustang Bio is currently under evaluation in z score category among related companies.
Mustang Bio Institutional Holders
Institutional Holdings refers to the ownership stake in Mustang Bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Mustang Bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Mustang Bio's value.| Shares | Macquarie Group Ltd | 2023-12-31 | 8 K | Fmr Inc | 2023-12-31 | 7.2 K | Tower Research Capital Llc | 2023-12-31 | 6.4 K | U.s. Bancorp | 2023-12-31 | 1000 | Ubs Group Ag | 2023-12-31 | 1000 | Nbc Securities Inc | 2023-09-30 | 400 | Advisor Group Holdings, Inc. | 2023-12-31 | 361 | Bank Of America Corp | 2023-12-31 | 211 | Wells Fargo & Co | 2023-12-31 | 150 | Armistice Capital, Llc | 2023-12-31 | 435.8 K | Vanguard Group Inc | 2023-12-31 | 179.6 K |
Mustang Fundamentals
| Return On Equity | -2.22 | ||||
| Return On Asset | -0.58 | ||||
| Current Valuation | (208.83 K) | ||||
| Shares Outstanding | 9.54 M | ||||
| Shares Owned By Insiders | 22.76 % | ||||
| Shares Owned By Institutions | 10.10 % | ||||
| Number Of Shares Shorted | 177.98 K | ||||
| Price To Earning | (11.40) X | ||||
| Price To Book | 42.91 X | ||||
| EBITDA | (48.5 M) | ||||
| Net Income | (51.6 M) | ||||
| Cash And Equivalents | 107.37 M | ||||
| Cash Per Share | 1.01 X | ||||
| Total Debt | 2.5 M | ||||
| Debt To Equity | 0.35 % | ||||
| Current Ratio | 9.96 X | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (49.48 M) | ||||
| Short Ratio | 0.54 X | ||||
| Earnings Per Share | (6.00) X | ||||
| Target Price | 14.33 | ||||
| Number Of Employees | 80 | ||||
| Beta | 1.54 | ||||
| Market Capitalization | 3.55 M | ||||
| Total Asset | 17.74 M | ||||
| Retained Earnings | (380.97 M) | ||||
| Working Capital | (4.03 M) | ||||
| Current Asset | 42.37 M | ||||
| Current Liabilities | 3.93 M | ||||
| Net Asset | 17.74 M |
About Mustang Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mustang Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mustang Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mustang Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Mustang Bio Piotroski F Score and Mustang Bio Valuation analysis. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Mustang Stock analysis
When running Mustang Bio's price analysis, check to measure Mustang Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mustang Bio is operating at the current time. Most of Mustang Bio's value examination focuses on studying past and present price action to predict the probability of Mustang Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mustang Bio's price. Additionally, you may evaluate how the addition of Mustang Bio to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Mustang Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.00) | Revenue Per Share (0) | Return On Assets (0.58) | Return On Equity (2.22) |
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.